Transforming Growth Factor-β1 Induces Invasion Ability of HSC-4 Human Oral Squamous Cell Carcinoma Cells Through the Slug/Wnt-5b/MMP-10 Signalling Axis
Overview
Authors
Affiliations
Molecular mechanism underlying the invasion of oral cancer cells remains to be clarified. We previously demonstrated that transforming growth factor-β1 (TGF-β1) induces the expression of mesenchymal markers in human oral squamous cell carcinoma HSC-4 cells. Intriguingly, the expression of the epithelial-mesenchymal transition-related transcription factor Slug was also significantly upregulated upon TGF-β1 stimulation. However, the mechanism by which Slug transduces the TGF-β1-induced signal to enhance the invasiveness of HSC-4 cells is poorly understood. Proteomic analysis revealed that the expression of matrix metalloproteinase (MMP)-10 was upregulated in TGF-β1-stimulated cells. Additionally, a Boyden chamber assay revealed that the TGF-β1-induced increase in invasiveness of HSC-4 cells was significantly inhibited by MMP-10 small interfering RNA (siRNA). Intriguingly, Slug siRNA suppressed TGF-β1-induced expression of MMP-10. These results suggest that TGF-β1 induces invasion in HSC-4 cells through the upregulation of MMP-10 expression in a Slug-dependent manner. On the other hand, Slug siRNA suppressed TGF-β1-induced Wnt-5b expression. Wnt-5b significantly induced MMP-10 expression, whereas Wnt-5b siRNA suppressed the TGF-β1-induced increase in invasiveness, suggesting that TGF-β1-induced expression of MMP-10 and the resulting upregulation of invasiveness are mediated by Wnt-5b. Overall, these results suggest that TGF-β1 stimulates HSC-4 cell invasion through the Slug/Wnt-5b/MMP-10 signalling axis.
Motizuki M, Yokoyama T, Saitoh M, Miyazawa K J Biol Chem. 2023; 300(1):105580.
PMID: 38141763 PMC: 10821601. DOI: 10.1016/j.jbc.2023.105580.
RUNX1 promotes liver fibrosis progression through regulating TGF-β signalling.
Guo Z, Liu X, Zhao S, Sun F, Ren W, Ma M Int J Exp Pathol. 2023; 104(4):188-198.
PMID: 37070207 PMC: 10349244. DOI: 10.1111/iep.12474.
Calanca N, Binato S, da Silva S, Brentani H, Sennes L, Pinto C Biomedicines. 2021; 9(9).
PMID: 34572445 PMC: 8469518. DOI: 10.3390/biomedicines9091258.
WNT5B in Physiology and Disease.
Suthon S, Perkins R, Bryja V, Miranda-Carboni G, Krum S Front Cell Dev Biol. 2021; 9:667581.
PMID: 34017835 PMC: 8129536. DOI: 10.3389/fcell.2021.667581.
Genetic alterations and clinical dimensions of oral cancer: a review.
Karunakaran K, Muniyan R Mol Biol Rep. 2020; 47(11):9135-9148.
PMID: 33085051 DOI: 10.1007/s11033-020-05927-0.